Clustered cases of Candida auris colonization: Roles of the infection prevention and control department and the mycology laboratory in controlling transmission.

IF 2.7 3区医学 Q3 INFECTIOUS DISEASES

Medical mycology Pub Date : 2025-04-02 DOI:10.1093/mmy/myaf033

Claire Cottrel, Marie Regad, Charlotte Arnal, Sandrine Henard, Marie Desnos-Olivier, Alain Lozniewski, Alexandre Alanio, Anne-Claire Bursztejn, Julie Lizon, Anne Debourgogne

引用次数: 0

Abstract

Candida auris is an emerging yeast that is responsible for outbreaks via nosocomial transmission. This study describes two cases of C. auris colonization, with confirmed interhospital transmission in the absence of travel history for the index case, although multiple risk factors were present. The role of the infection prevention and control department is essential in implementing barrier measures to limit yeast transmission, whereas the mycology laboratory plays a crucial role in the rapid and effective detection of potential contact cases, as well as environmental contamination.

查看原文本刊更多论文

聚集性耳念珠菌定植：感染防控部门和真菌学实验室在控制传播中的作用。

耳念珠菌是一种新兴酵母菌，可通过医院传播引起疫情。本研究描述了两例金黄色葡萄球菌定植病例，虽然存在多种危险因素，但在指示病例没有旅行史的情况下，证实了医院间传播。感染预防和控制部门的作用在实施屏障措施以限制酵母菌传播方面至关重要，而真菌学实验室在快速有效地检测潜在接触病例以及环境污染方面发挥着至关重要的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medical mycology 医学-兽医学

CiteScore

5.70

自引率

3.40%

发文量

632

审稿时长

12 months

期刊介绍： Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.